Stock Picks

Mar. 5, 2026

GW&K Investment Management Trims Neurocrine Biosciences Stake

Institutional investor reduces position in biotech company by 2.9%

Mar. 5, 2026

ARK Investment Management Boosts Stake in Illumina

Institutional investor increases position in life sciences company by 25.7%

Mar. 3, 2026

Teachers Retirement System of Kentucky Cuts Qualcomm Stock Holdings

Institutional investor reduces stake in wireless technology company

Mar. 3, 2026

JPMorgan Chase Boosts Stake in American Assets Trust

Investment firm increases ownership in real estate investment trust by nearly 190%

Mar. 3, 2026

DNB Asset Management Boosts Stake in Neurocrine Biosciences

The institutional investor increased its holdings in the biopharmaceutical company by 8% in the third quarter.

Mar. 3, 2026

Halozyme Therapeutics Stock Holdings Reduced by Rafferty Asset Management

Institutional investor cuts stake in biopharmaceutical company by over 40%

Mar. 3, 2026

Intech Investment Management Reduces DexCom Stake

Institutional investor sells over 66,000 shares of medical device company

Mar. 3, 2026

Rafferty Asset Management Boosts DexCom Holdings

Institutional investor increases stake in medical device company by 19.3% in Q3

Mar. 3, 2026

Rafferty Asset Management Reduces Biogen Stake

Institutional investor sells over 21,000 shares of biotech company

Mar. 2, 2026

Enphase Energy Shareholders Seek Compensation for Losses

Robbins LLP Investigating Allegations of Misleading Investors About Channel Inventory and Tax Credit Impacts

Feb. 28, 2026

Reviewing Solana (NASDAQ:HSDT) & Tandem Diabetes Care (NASDAQ:TNDM)

Comparing the financial performance and outlook of two small-cap medical companies

Feb. 26, 2026

HighTower Advisors Trims Stake in DexCom Medical Device Company

Hedge fund reduces holdings in glucose monitoring firm by over 88% in Q3

Feb. 25, 2026

Robbins LLP Urges TCPC Investors to Join Class Action Lawsuit

Law firm investigating allegations that BlackRock TCP Capital Corp. misled investors about its business prospects

Feb. 11, 2026

Qualcomm Seen as No-Brainer AI Chip Stock Despite Near-Term Headwinds

Chipmaker's long-term potential outweighs short-term smartphone industry pressures, say analysts.

Feb. 9, 2026

Robbins LLP Reminds Investors of Mereo BioPharma Group plc Class Action Deadline

Law firm alerts shareholders to lead plaintiff deadline in lawsuit against biopharmaceutical company.